Boys cannot have Turner syndrome. Turner syndrome requires the partial or complete absence of one X chromosome in a person with a female phenotype, which makes it biologically restricted to girls and women. However, the reason this question comes up so often is that a separate condition, Noonan syndrome, causes strikingly similar physical features in boys and is sometimes informally called “male Turner syndrome.”
Why Turner Syndrome Only Affects Females
Turner syndrome occurs when one of the two X chromosomes is missing or partially deleted. Since typical male development depends on having one X and one Y chromosome, a male who lost his only X chromosome would not survive. A female with Turner syndrome still has one functioning X, which is enough to sustain life but leads to a range of developmental differences including short stature, heart defects, and ovarian insufficiency.
Turner syndrome affects at least 1 in every 2,500 live-born females. There is no equivalent version that occurs in males with an XY chromosome pair.
What About 45,X/46,XY Mosaicism?
There is one scenario where a Turner-related chromosome pattern shows up in someone who develops as male. In a condition called 45,X/46,XY mosaicism, some cells in the body are missing the Y chromosome (carrying only 45,X, the Turner karyotype) while other cells have the typical 46,XY male pattern. This is not Turner syndrome, but it does involve the same chromosomal abnormality in a portion of cells.
An international survey of 92 prenatally diagnosed cases found that the vast majority, about 95%, of fetuses with this mosaicism had normal male genitalia at birth. Among 76 cases that received physical exams, 75 were male and only one was female. The condition can sometimes cause genital differences or abnormal development of the gonads (found in about 27% of cases examined), but most of these individuals live as phenotypically normal males. This is classified as mixed gonadal dysgenesis, not Turner syndrome.
Noonan Syndrome: The Condition Often Confused With Turner
Noonan syndrome is the genetic condition most commonly mistaken for Turner syndrome, and it affects both boys and girls equally. It occurs in roughly 1 in 2,500 births. The overlap in physical features is significant: short stature, a broad or webbed neck, widely spaced nipples, an unusual chest shape, and congenital heart defects. These similarities are why some older medical literature referred to Noonan syndrome as “male Turner syndrome,” though that label is outdated and inaccurate.
The key difference is genetic. Turner syndrome involves a missing or damaged sex chromosome. Noonan syndrome is caused by mutations in genes that regulate a specific cell-signaling pathway. The most common mutation, found in about 50% of cases, affects the PTPN11 gene. Another 10 to 20% of cases involve the SOS1 gene, with rarer mutations in RAF1 and KRAS each accounting for less than 5%. Noonan syndrome follows an autosomal dominant inheritance pattern, meaning a child needs only one copy of the mutated gene from either parent to develop the condition.
How Noonan Syndrome Looks in Boys
Facial features are one of the earliest clues. Boys with Noonan syndrome typically have wide-set eyes that slant downward with droopy lids, often pale blue or green in color. The ears sit low and are rotated backward. The jaw tends to be small, and the roof of the mouth is often highly arched. These features are most noticeable in young and middle childhood, becoming subtler with age as the face appears sharper.
The chest shape is distinctive: the upper breastbone often pushes outward while the lower portion sinks inward, creating a combination of pectus carinatum above and pectus excavatum below. The neck may be broad or webbed, and the skin can appear thin and transparent over time.
Short stature is present in 50 to 70% of boys with Noonan syndrome. Untreated men in European studies reach a median adult height of about 162.5 cm (5 feet 4 inches), roughly 2 standard deviations below average. Growth charts specific to Noonan syndrome show that the 50th percentile for height overlaps with the 3rd percentile of the general population. Growth hormone therapy can improve height velocity, though the response varies depending on the underlying genetic mutation.
Heart Involvement in Noonan Syndrome
Heart defects are present in about 81% of people with Noonan syndrome, but the pattern differs from Turner syndrome. The most common defect is pulmonary valve stenosis, a narrowing of the valve between the heart and the lungs, found in 57% of cases. About 32% have a hole between the upper chambers of the heart, and 16% develop a thickening of the heart muscle called hypertrophic cardiomyopathy. In Turner syndrome, the typical heart concerns involve the aorta rather than the pulmonary valve, which is one way doctors distinguish the two conditions.
Puberty and Fertility in Boys
Puberty in boys with Noonan syndrome is often delayed, with the average onset around age 14 compared to roughly 11 or 12 in the general population. It typically starts on its own without medical intervention.
Fertility is a more significant concern. Up to 80% of boys with Noonan syndrome have cryptorchidism, where one or both testes do not descend into the scrotum. This was long considered the primary driver of reduced fertility in these men. More recent evidence suggests the picture is more complex. The PTPN11 gene is active in the cells responsible for sperm production, and gonadal dysfunction can occur even in men whose testes descended normally. Hormonal testing in affected men often shows elevated FSH levels alongside markers of impaired function in the cells that support sperm development. Some men with Noonan syndrome have low sperm counts or produce no sperm at all, though fertility outcomes vary widely depending on the specific genetic mutation and individual factors.
How Noonan Syndrome Is Diagnosed
Diagnosis relies on a combination of physical features, family history, and genetic testing. No single standardized scoring system is universally used, though clinical criteria have been proposed. Doctors look for the characteristic facial features, short stature, heart defects, developmental delay of variable degree, the distinctive chest shape, and, in boys, undescended testes. Blood clotting abnormalities are also common and may show up on routine coagulation tests, including conditions like von Willebrand disease, low platelet counts, or deficiencies in various clotting factors.
Genetic testing can confirm the diagnosis in 70 to 80% of cases by identifying a mutation in one of the known genes. The remaining 20 to 30% of clinically diagnosed cases have no identifiable mutation with current testing, which does not rule out the condition. A family history showing affected males and females across generations supports the diagnosis, though many cases arise from new, spontaneous mutations with no family history at all.